Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis.


Journal

Scandinavian journal of rheumatology
ISSN: 1502-7732
Titre abrégé: Scand J Rheumatol
Pays: England
ID NLM: 0321213

Informations de publication

Date de publication:
Mar 2022
Historique:
pubmed: 13 7 2021
medline: 14 4 2022
entrez: 12 7 2021
Statut: ppublish

Résumé

To investigate aspects of validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease (SEMCD-Swe) scale in systemic sclerosis (SSc). A forward-backward translation procedure was used. Content validity was assessed through interviews with 11 people with SSc and 10 healthcare professionals. Construct validity, internal consistency, test-retest reliability, and floor and ceiling effects were evaluated in 104 SSc patients. The content validity of the SEMCD-Swe was interpreted as satisfactory, but some adjustments were made to increase the understanding. Confirmatory factor analysis supported a single-factor structure. Moderate to strong correlations between the SEMCD-Swe and Scleroderma Health Assessment Questionnaire; Multidimensional Assessment of Fatigue; Patient Health Questionnaire-8 (r Support for construct validity was indicated, as the SEMCD-Swe in SSc show a single-factor structure and is more strongly associated with pain, fatigue, depressive symptoms, interferences with daily activities, disability, and quality of life than with disease severity. Our results also indicate support for content validity and reliability. However, the responsiveness of the SEMCD-Swe needs to be tested.

Identifiants

pubmed: 34251963
doi: 10.1080/03009742.2021.1917142
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-119

Auteurs

M Mattsson (M)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Department of Physiotherapy, Sunderby Hospital, Luleå, Sweden.

G Sandqvist (G)

Department of Clinical Sciences, Lund University, Lund, Sweden.

R Hesselstrand (R)

Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Rheumatology, Skåne University Hospital, Lund, Sweden.

D Olsson (D)

Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.

L Kwakkenbos (L)

Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.

A Nordin (A)

Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Unit of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

C Boström (C)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Women's Health and Health Professionals Theme, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH